Clinical outcome after 36 months of treatment with injections of autologous blood for recurrent dislocation of the temporomandibular joint
| Autor: | K. Shimizutani, Shosuke Morita, Y.-i. Nakatani, Hiroaki Yoshida, S. Gamoh |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male Systemic disease medicine.medical_specialty Adolescent Autologous blood Joint Dislocations Recurrent dislocation Injections Intra-Articular 03 medical and health sciences Blood Transfusion Autologous Young Adult 0302 clinical medicine Recurrence Medicine Humans Aged Aged 80 and over Temporomandibular Joint business.industry 030206 dentistry Middle Aged Temporomandibular Joint Disorders medicine.disease Surgery Temporomandibular joint medicine.anatomical_structure Treatment Outcome Otorhinolaryngology 030220 oncology & carcinogenesis Anesthesia Chronic Disease Female Oral Surgery business Follow-Up Studies |
| Zdroj: | The British journal of oralmaxillofacial surgery. 56(1) |
| ISSN: | 1532-1940 |
| Popis: | We investigated the prognosis after three years of treatment for recurrent dislocation of the temporomandibular joint with autologous blood given intravenously in 21 patients with a mean (range) age 64 (17-92) years of whom 16 had coexisting systemic disease. The mean (range) follow up from the first injection was 64 (41-99) months. Eighteen patients had no recurrence during the first 36 months after their first injection, which showed that this minimally-invasive treatment was effective, particularly for those who had conditions that made a mouthpiece or operation unsuitable. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect